ArticleJournal of chemical information and modeling2026
Identification of Subtype-Selective Binding Sites in the Opioid Receptor Family.
Article in Journal of chemical information and modeling, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Selectivity is essential in drug discovery for finding or developing more effective opioid modulators. Structure-based approaches and binding kinetics effectively identify potential druggable regions and determine ligand candidates for improved therapies. In this study, we combined molecular dynamics simulations and funnel-metadynamics with charge density analyses to identify unique structural aspects of the main opioid receptors (ORs), including the mu (μOR), delta (δOR), and kappa (κOR). We found distinct conformational dynamics between the receptors, with the κOR extracellular vestibule tending to form a lid that covers its orthosteric site. Furthermore, we investigated how morphinan-scaffold ligands with distinct pharmacological effects bind to OR orthosteric sites and extracellular vestibules, identifying intermediate ligand states. The lowest-energy states of each complex reproduced the morphinan-like orientation revealed by experimental structures and experimental free energy of binding. Moreover, we determined the role of orthosteric subpockets and extracellular loops (ECLs) in stabilizing ligand-bound states, shedding light on ligand selectivity. Our results provide a detailed description, from an energetic perspective, of the conformational dynamics and structure-based selectivity determination within the OR family. These regions can be rationally targeted for designing and developing functionally selective opioid modulators with improved pharmacological effects in pain treatment or other OR-related diseases.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.